Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
US-2016057967-A1 · Mar 3, 2016 · US
US11773401B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11773401-B2 |
| Application number | US-201816770906-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2018 |
| Priority date | Dec 7, 2017 |
| Publication date | Oct 3, 2023 |
| Grant date | Oct 3, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of decreasing conversion of nicotine to nornicotine is provided herein. The methods includes administering at least one basic region/leucine zipper (bZIP) type transcription factor inhibitor to an organism in need thereof. Also provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a bZIP type transcription factor binding site on a promoter of a nicotine N-demethylase (NND). Further provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a plant genome to knockout at least one bZIP type transcription factor.
Opening claim text (preview).
What is claimed is: 1. A method of decreasing conversion of nicotine to nornicotine in a Nicotiana plant, the method comprising mutating a plant genome to knockout a Nicotiana basic region/leucine zipper (bZIP) transcription factor comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 4, 5, and 6; and measuring expression of genes encoding nicotine demethylases, measuring nicotine levels, measuring nornicotine levels, and/or measuring N-nitrosonornicotine levels in the Nicotiana plant. 2. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is a group C bZIP transcription factor. 3. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP1a (SEQ ID NO: 2). 4. The method of claim 1 , comprising mutating the plant genome to knockout at least two of the Nicotiana bZIP transcription. 5. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is a group S bZIP transcription factor. 6. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP1b (SEQ ID NO: 4). 7. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP2a (SEQ ID NO: 5). 8. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP2b (SEQ ID NO: 6).
Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title
Leaves · CPC title
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title
Antisense · CPC title
MicroRNAs, miRNAs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.